Purchases and Sales Made in Q4 2022 in Harmony Biosciences Holdings, Inc. (HRMY)
This table provides information about the institutional ownership of Harmony Biosciences Holdings, Inc. (HRMY) during Q4 2022. The information is specifically focused on institutions that hold shares of Harmony Biosciences Holdings, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 10, 2023
Q4 2022
|
Sei Investments CO
Oaks, PA |
SELL
|
- |
-21.4K- 23.87% |
$970K - $1.3M
|
68.1K
$2.23M
|
|
Feb 13, 2023
Q4 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-23.5K- 20.19% |
$1.07M - $1.43M
|
92.8K
$3.04M
|
|
Jan 27, 2023
Q4 2022
|
Rice Hall James & Associates, LLC
|
SELL
|
- |
-23.8K- 22.43% |
$1.08M - $1.45M
|
82.3K
$2.69M
|
|
Jan 25, 2023
Q4 2022
|
Calamos Advisors LLC
|
SELL
|
- |
-24.1K- 32.99% |
$1.09M - $1.47M
|
49K
$1.6M
|
|
Feb 14, 2023
Q4 2022
|
Rothschild & CO Asset Management Us Inc.
New York, NY |
SELL
|
- |
-27.2K- 14.13% |
$1.23M - $1.65M
|
165K
$5.4M
|
|
Feb 13, 2023
Q4 2022
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-30K- 11.74% |
$1.36M - $1.83M
|
226K
$7.38M
|
|
Feb 14, 2023
Q4 2022
|
Man Group PLC
London, X0 |
SELL
|
- |
-32.6K- 12.1% |
$1.48M - $1.99M
|
237K
$7.75M
|
|
Feb 14, 2023
Q4 2022
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
SELL
|
- |
-42.1K- 10.01% |
$1.91M - $2.57M
|
379K
$12.4M
|
|
Feb 14, 2023
Q4 2022
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-47.3K- 11.16% |
$2.15M - $2.88M
|
376K
$12.3M
|
|
Feb 03, 2023
Q4 2022
|
Lisanti Capital Growth, LLC
|
SELL
|
- |
-54.2K- 21.86% |
$2.46M - $3.3M
|
194K
$6.34M
|
|
May 14, 2024
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-56.6K- 34.17% |
$2.57M - $3.45M
|
109K
$3.57M
|
|
Feb 13, 2023
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-56.6K- 34.17% |
$2.57M - $3.45M
|
109K
$3.57M
|
|
Feb 13, 2023
Q4 2022
|
American Century Companies Inc
Kansas City, MO |
SELL
|
- |
-60.6K- 8.49% |
$2.75M - $3.69M
|
653K
$21.4M
|
|
Feb 14, 2023
Q4 2022
|
Bellevue Group Ag
Kuesnacht, V8 |
SELL
|
- |
-61K- 9.28% |
$2.77M - $3.72M
|
596K
$19.5M
|
|
Feb 08, 2023
Q4 2022
|
Russell Investments Group, Ltd.
|
SELL
|
- |
-62.7K- 34.37% |
$2.85M - $3.82M
|
120K
$3.91M
|
|
Feb 13, 2023
Q4 2022
|
Royce & Associates LP
|
SELL
|
- |
-65.7K- 22.21% |
$2.98M - $4M
|
230K
$7.53M
|
|
Feb 13, 2023
Q4 2022
|
Massachusetts Financial Services CO
Boston, MA |
SELL
|
- |
-75.3K- 18.14% |
$3.42M - $4.59M
|
340K
$11.1M
|
|
Feb 14, 2023
Q4 2022
|
Ven Bio Partners LLC
San Francisco, CA |
SELL
|
- |
-90.3K- 8.02% |
$4.1M - $5.5M
|
1.04M
$33.9M
|
|
May 23, 2023
Q4 2022
|
Royce & Associates LP
|
SELL
|
- |
-102K- 30.71% |
$4.63M - $6.22M
|
230K
$7.53M
|
|
Feb 14, 2023
Q4 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-104K- 9.66% |
$4.72M - $6.34M
|
973K
$31.8M
|
|
Feb 15, 2023
Q4 2022
|
Ashford Capital Management Inc
Wilmington, DE |
SELL
|
- |
-134K- 27.33% |
$6.09M - $8.17M
|
357K
$11.7M
|
|
Feb 13, 2023
Q4 2022
|
Nan Fung Group Holdings LTD
Central, K3 |
SELL
|
- |
-142K- 27.85% |
$6.46M - $8.67M
|
369K
$12.1M
|
|
Feb 14, 2023
Q4 2022
|
Polar Capital Holdings PLC
London, X0 |
SELL
|
- |
-175K- 24.67% |
$7.95M - $10.7M
|
534K
$17.5M
|
|
Feb 14, 2023
Q4 2022
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-223K- 14.72% |
$10.1M - $13.6M
|
1.29M
$42.3M
|
|
Feb 14, 2023
Q4 2022
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-460K- 77.97% |
$20.9M - $28M
|
130K
$4.25M
|
|
Feb 13, 2023
Q4 2022
|
Vivo Capital, LLC
Palo Alto, CA |
SELL
|
- |
-794K- 23.35% |
$36M - $48.4M
|
2.61M
$85.3M
|